Wave Life Sciences (WVE) Earnings Date
Does this company deliver against its own promises? Earnings are a check on the thesis, not a catalyst to chase.
1 of 2 scored quarters beat.
| Report | Est EPS | Act EPS | Surprise | Est rev | Act rev | Rev surp. | Reaction |
|---|---|---|---|---|---|---|---|
| Oct 27, 20268-K, before open · 7:30 am ET | −0.33 | −0.30 | +8.8% | $4.5M | $13.2M | +191.6% | +7.5%release day |
| Jul 30, 20268-K, before open · 7:38 am ET | −0.30 | −0.34 | −13.4% | $7.4M | $2.3M | −69.5% | −0.9%release day |
| Feb 26, 20268-K, before open · 7:37 am ET | — | −0.29 | — | — | $17.2M | — | +5.6%release day |
| Nov 10, 20258-K, before open · 7:35 am ET | — | −0.32 | — | — | $7.6M | — | −10.3%release day |
| Jul 30, 20258-K, before open · 7:35 am ET | — | −0.31 | — | — | $8.7M | — | −1.9%release day |
| May 8, 20258-K, before open · 7:36 am ET | — | −0.29 | — | — | $9.2M | — | +0.8%release day |
| Nov 12, 20248-K, before open · 7:35 am ET | — | −0.47 | — | — | −$7.7M | — | −3.3%release day |
| Aug 8, 20248-K, before open · 7:37 am ET | — | −0.25 | — | — | $19.7M | — | −4.0%release day |
Estimate-vs-actual scoring began Jul 2026 and is still accruing: 2 of the 8 quarters above carry a scored estimate. We never backfill an estimate we didn't observe.
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 11 | 6 | 14 | 15 |
| Avg estimate | −0.32 | −0.34 | −1.11 | −1.29 |
| Low estimate | −0.36 | −0.38 | −1.20 | −1.86 |
| High estimate | −0.30 | −0.29 | −0.87 | −0.47 |
| Year-ago EPS | −0.29 | — | −1.21 | −1.11E |
| Implied growth | — | — | — | — |
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 12 | 6 | 14 | 15 |
| Avg estimate | $10.4M | $9.7M | $63.6M | $39.0M |
| Low estimate | $3.4M | $7.6M | $44.6M | $28.3M |
| High estimate | $16.9M | $13.5M | $72.9M | $62.4M |
| Year-ago revenue | $17.2M | — | $42.7M | $63.6ME |
| Implied growth | −39.5% | — | +48.9% | −38.8% |
| Snapshot age | Dec '26, period ending Dec 30, 2026 | Mar '27, period ending Mar 30, 2027 | FY26, period ending Dec 31, 2026 | FY27, period ending Dec 31, 2027 |
|---|---|---|---|---|
| Current estimate | −0.32 | −0.34 | −1.11 | −1.29 |
| 7 days ago | −0.32 | — | −1.10 | −1.30 |
| 30 days ago | −0.33 | — | −1.13 | −1.30 |
| 60 days ago | −0.33 | — | −1.12 | −1.32 |
| 90 days ago | −0.33 | — | −1.11 | −1.29 |
Estimate history accrues from our nightly snapshots. The 7/30/60/90-day rows fill in as tracking continues. Each column follows one fiscal period back through our snapshots; a dash means we had not recorded that period at that age. A rising bar makes a beat streak more meaningful; a falling one manufactures beats.
Dec '26 quarter consensus moved $−0.33 → $−0.32 over 90 tracked days, the same quarter at both ends. Per-analyst up/down revision counts aren't in our data feed. We show the bar's actual movement instead of guessing.
Common questions
What were Wave Life Sciences' latest quarterly earnings?
Wave Life Sciences reported diluted EPS of −0.30 and revenue of $13.2M on Oct 27, 2026.
How did Wave Life Sciences' stock move after its last earnings report?
Wave Life Sciences moved +7.5% in the session after its Oct 27, 2026 report.

